Michael Mingueneau
Vice President, Immunology Sail Biomedicines
Seminars
Tuesday 22nd July 2025
In Vivo Reversible Programming of T Cells With SAIL’s Targeted NP-eRNA Platform for the Treatment of Autoimmune Diseases & Beyond
3:00 pm
